Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Nanchang University | China

Dr. Zhiwei Zhong’s research focuses on molecular oncology, nanomedicine, and biomarker discovery in complex diseases such as pancreatic cancer, hepatocellular carcinoma, thyroid eye disease, and venous thromboembolism. His studies integrate bioinformatics, molecular biology, and nanotechnology to uncover therapeutic targets and diagnostic biomarkers. Zhong has contributed to several high-impact publications in PLOS One, Cancer Cell International, Oncology Reports, Digestive Diseases and Sciences, and SN Applied Sciences. His notable works include identifying key extracellular proteins (EGFR, CD44, and CXCL8) as potential biomarkers in thyroid eye disease, elucidating the regulatory role of lncRNA FTX in suppressing NAFLD progression to hepatocellular carcinoma via Kupffer cell polarization, and exploring nanoparticle-based drug delivery systems for targeted thrombolysis and cancer therapy. He has also investigated tumor suppressor mechanisms involving KLF9 and CHD1L in pancreatic cancer, providing insights into tumor proliferation, invasion, and survival pathways. His research contributions advance the understanding of molecular pathogenesis, precision diagnostics, and targeted nanotherapeutic strategies in human diseases.

Profile: ORCID

Featured Publications

  1. He, S., Nie, H., Yin, X., & Zhong, Z. (2025, April). Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease. PLOS ONE, 20(4), e0322415. https://doi.org/10.1371/journal.pone.0322415

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Published on by Forensic Scientist

Dr. Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Sandikli State Hospital | Turkey

Dr. Begum Ertan is an accomplished medical doctor and specialist in Gynecology and Obstetrics, serving at Afyonkarahisar Sandikli State Hospital. She is recognized for her dedication to advancing women’s reproductive health, blending clinical expertise with a strong commitment to academic research. Her work spans adenomyosis diagnosis, infertility treatment, IVF success prediction, and gynecologic oncology. Actively engaged in professional societies, she is a core group member of the Turkish Endometriosis and Adenomyosis Society. Dr. Ertan combines patient-centered care with cutting-edge scientific approaches, striving to improve diagnostic accuracy, treatment outcomes, and overall quality of life for women.

Professional Profile

Scopus

Education

Dr. Ertan completed her medical degree at Celal Bayar University, Faculty of Medicine, where she laid a strong foundation in clinical sciences and patient care. She then specialized in Obstetrics and Gynecology at Dokuz Eylül University, Faculty of Medicine, developing advanced skills in reproductive medicine, maternal-fetal health, and minimally invasive surgical techniques. Her education was enriched by exposure to diverse clinical cases and participation in academic projects, fostering her dual role as a skilled clinician and committed researcher.

Experience

With extensive experience as a Gynecology and Obstetrics Specialist, Dr. Ertan has managed complex cases involving high-risk pregnancies, reproductive endocrinology, and gynecologic surgery. She has contributed to multidisciplinary medical teams, enhancing patient outcomes through evidence-based approaches. Her professional activities include presenting original research at leading national and international conferences, authoring peer-reviewed publications, and writing academic book chapters on endometriosis, infertility, and hormonal therapies. In addition to her hospital duties, she actively participates in community health initiatives, delivering educational seminars on women’s health and hygiene.

Research Interests

Dr. Ertan’s research is driven by a commitment to improving women’s reproductive health through innovative diagnostic and therapeutic methods. She is particularly interested in adenomyosis detection using advanced imaging modalities, identifying predictive factors for IVF success, evaluating the impact of early pregnancy findings on pregnancy outcomes, and exploring rare gynecologic pathologies. Her studies also address the role of hysteroscopic evaluation in abnormal uterine bleeding and the relationship between ovarian conditions and fertility potential. By integrating clinical insight with research innovation, she aims to bridge the gap between academic findings and real-world patient care.

Awards

Dr. Ertan’s professional trajectory reflects the qualities sought in the Young Researcher Award  innovation, dedication, and measurable contributions to the field. Her growing portfolio of scientific publications, her active participation in professional societies, and her involvement in public health education underscore her status as a promising and impactful early-career researcher in obstetrics and gynecology.

Publications

  • Title: Prediction of adenomyosis according to revised definitions of morphological uterus sonographic assessment features
    Journal: Frontiers in Medicine
    Published on: August 2024

  • Title: Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study
    Journal: Turkish Journal of Reproductive Medicine and Surgery
    Published on: 2024

  • Title: Impact of ovarian cysts observed on the initial day of ovulation induction on the success rates in IVF cycles
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Correlation of adenomyosis risk factors with pathologic diagnosis
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Pregnancy Loss Prediction Based on Early First Trimester Ultrasound
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Ovarian hilus cell hyperplasia and sertoli-leydig cell tumor in a patient with postmenopausal virilization: a rare case report
    Journal: Aegean Journal of Obstetrics and Gynecology
    Published on: December 2021

Conclusion

Dr. Begum Ertan embodies the profile of an emerging leader in reproductive medicine. Her clinical expertise, research productivity, and academic contributions have already made a significant impact on the field. Through her continued work in advanced gynecologic diagnostics, fertility treatment, and women’s health advocacy, she demonstrates exceptional promise as a young researcher. Her commitment to bridging scientific innovation with practical healthcare solutions makes her a strong and deserving candidate for the Young Researcher Award.

Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Mr. Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

University of the Mountains | Cameroon

Mr. Romaric Tuono De Manfouo is an accomplished biomedical researcher specializing in hematology, infectious diseases, and public health. His work integrates laboratory investigations, epidemiological studies, and translational research to address pressing health challenges in sub-Saharan Africa. With a proven record of impactful scientific contributions, he has been involved in multidisciplinary projects exploring blood disorders, viral infections, and immunological responses. His ability to conduct rigorous clinical studies and collaborate with diverse research teams has positioned him as a respected figure in his field, committed to improving patient care through scientific advancement.

Professional Profile

Scopus

ORCID

Education

Mr. Romaric’s academic journey reflects a strong foundation in health sciences, with a focus on biomedical and clinical research. His studies provided comprehensive training in hematology, immunology, molecular biology, and epidemiology, allowing him to develop the expertise necessary to investigate complex medical conditions. Through extensive research training and practical exposure, he has acquired the skills to design and execute studies that address both laboratory-based and population-level health concerns.

Experience

Throughout his career, Mr. Romaric has worked in academic institutions, research laboratories, and collaborative health projects, contributing to knowledge generation and clinical decision-making. He has been a lead investigator and co-author on studies examining hematological profiles, hemostasis, infectious disease prevalence, and genetic conditions affecting blood health. His experience spans from advanced diagnostic testing to community-based data collection, making his work relevant to both clinical medicine and public health policy.

Research Interest

His research interests center on understanding the mechanisms and epidemiology of blood-related disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, and alloimmunization in chronic illness. He is equally engaged in studying infectious diseases including viral hepatitis and their impact on vulnerable populations such as pregnant women, newborns, and high-risk adult groups. His goal is to generate evidence that informs targeted interventions, improves early detection, and enhances patient outcomes in low-resource settings.

Awards

Mr. Romaric’s scientific achievements have been recognized through his publication record, invitations to review for international peer-reviewed journals, and collaborations with multidisciplinary research teams. His expertise is sought after in both academic and clinical research contexts, and his work continues to contribute to advancements in hematology, epidemiology, and public health.

Publications

  • Title: Abnormalities of Hemostasis in Sickle Cell Patients and Predisposition to Thrombotic Risk: A Systematic Review and Meta-Analysis
    Journal: Preprint
    Published on: 2025

  • Title: Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross‐Sectional Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Cytopenias and Associated Factors in Patients Living With HIV on ARV Treatment in Cameroon: An Analytical Cross‐Sectional Study
    Journal: Advances in Hematology
    Published on: 2025

  • Title: Haptoglobin Gene Polymorphism and Iron Profile in Sickle Cell Disease Patients With Inflammation in Yaounde, Cameroon
    Journal: Molecular Genetics & Genomic Medicine
    Published on: 2024

  • Title: Hematological And Hemostasis Profile, Thrombotic Risk In Sickle Cell Patient In Cameroon: An Analytical Cross-Sectional Study
    Journal: Hematology and Disorders
    Published on: 2024

  • Title: Hyperuricemia and Associated Factors: The Case of Outpatients at the Bafoussam Regional Hospital-Cameroon, an Analytical Cross-Sectional Study
    Journal: Health Science Reports
    Published on: 2024

Conclusion

Mr. Romaric Tuono De Manfouo exemplifies excellence in biomedical research, combining academic rigor, clinical insight, and a commitment to public health. His body of work reflects a consistent focus on improving the understanding, diagnosis, and management of hematological and infectious diseases in African populations. Through his scholarly publications, peer-review contributions, and research leadership, he continues to make significant contributions that enhance scientific knowledge and healthcare delivery. His achievements make him a worthy nominee for the Best Researcher Award, representing dedication, innovation, and scientific integrity.